Sort
25,944 grants matching “neurodegeneration”
Mitochondrial Energy Sensing and Neuronal Function
$543,486Andrew Phillip Wojtovich · University Of Rochester · R01 · FY2025 · NS
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
$543,375Laxmikant S Deshpande · Virginia Commonwealth University · UG3 · FY2023 · NS
Redox-sensitive activation of REDD1 in diabetic retinopathy
$543,314Michael D. Dennis · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · EY
Effects of Iron Accumulation in Intracortical Implants and Protection by Iron Chelation
$543,265Abhishek Prasad · University Of Miami School Of Medicine · R01 · FY2025 · NS
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease
$543,137Malcolm A Leissring · University Of California-Irvine · R01 · FY2022 · AG
High-speed opto-fluidics to screen entire nervous system in aging and disease
$543,034Adela Ben-Yakar · University Of Texas At Austin · R01 · FY2014 · AG
Development of Mouse Models of PD
$543,008Jie Shen · Brigham And Women'S Hospital · P50 · FY2009 · NS
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
$543,000Jiou Wang · Johns Hopkins University · R01 · FY2020 · NS
Mechanisms of RNA and Protein Dysregulations in ALS/FTD Associated with FUS and Ubiquilin 2
$543,000Jiou Wang · Johns Hopkins University · R01 · FY2019 · NS
Identify common mechanisms of neurodegeneration between Alzheimer's disease and Down syndrome
$542,974Antonella Caccamo · Arizona State University-Tempe Campus · R01 · FY2018 · AG
Development and Maintenance of Lens Transparency
$542,904University Of Washington · R01 · FY2004 · EY
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease
$542,850Myriam Heiman · Massachusetts Institute Of Technology · R35 · FY2023 · NS
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease
$542,850Myriam Heiman · Massachusetts Institute Of Technology · R35 · FY2022 · NS
Molecular Mechanisms Underlying Cell Type-Specific Vulnerability in Huntingtonâs Disease
$542,850Myriam Heiman · Massachusetts Institute Of Technology · R35 · FY2025 · NS
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease
$542,653Joshua M Shulman · Baylor College Of Medicine · R01 · FY2020 · AG
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease
$542,653Joshua M Shulman · Baylor College Of Medicine · R01 · FY2019 · AG
Understanding Amyloid Pathology - Multiomic Activity Imaging of Plaque Formation Dynamics (AmyMAP)
$542,590Jeffrey Nicholas Savas · Northwestern University At Chicago · R01 · FY2024 · AG
Oxidative DNA Damage And Its Processing
$542,395Vilhelm A Bohr · National Institute On Aging · ZIA · FY2014 · AG
Reprogramming proinflammatory microglia by restoring mitochondrial function
$542,296Brian M Polster · University Of Maryland Baltimore · R01 · FY2023 · NS
Training in the Molecular Biology of Neurodegeneration
$542,073Bruce A Yankner · Harvard Medical School · T32 · FY2014 · AG
Vanderbilt Interdisciplinary Training Program in Alzheimer's Disease
$542,053Angela L. Jefferson · Vanderbilt University · T32 · FY2025 · AG
Training in age related neurodegenerative diseases
$542,019Virginia M Lee · University Of Pennsylvania · T32 · FY2023 · AG
Efficacy of GluR5 Antogonists Against Soman-Induced Seizures and Neuropathology
$541,966Maria F Braga · Henry M. Jackson Fdn For The Adv Mil/Med · U01 · FY2015 · NS
Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer disease
$541,947Malcolm A Leissring · University Of California-Irvine · R01 · FY2025 · AG
Mechanisms by which the ketone body β-hydroxybutyrate counteracts tau pathogenesis
$541,835Xu Chen · University Of California, San Diego · R01 · FY2022 · AG